296 related articles for article (PubMed ID: 23731702)
1. Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signaling.
Kumar BN; Rajput S; Dey KK; Parekh A; Das S; Mazumdar A; Mandal M
BMC Cancer; 2013 Jun; 13():273. PubMed ID: 23731702
[TBL] [Abstract][Full Text] [Related]
2. COX-2 silencing enhances tamoxifen antitumor activity in breast cancer in vivo and in vitro.
Du Y; Shi A; Han B; Li S; Wu D; Jia H; Zheng C; Ren L; Fan Z
Int J Oncol; 2014 Apr; 44(4):1385-93. PubMed ID: 24535190
[TBL] [Abstract][Full Text] [Related]
3. Combining sorafenib with celecoxib synergistically inhibits tumor growth of non-small cell lung cancer cells in vitro and in vivo.
Zhang H; Li Z; Wang K
Oncol Rep; 2014 Apr; 31(4):1954-60. PubMed ID: 24549815
[TBL] [Abstract][Full Text] [Related]
4. An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells.
Aesoy R; Sanchez BC; Norum JH; Lewensohn R; Viktorsson K; Linderholm B
Mol Cancer Res; 2008 Oct; 6(10):1630-8. PubMed ID: 18922978
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
Kim CK; Joe YA; Lee SK; Kim EK; O E; Kim HK; Oh BJ; Hong SH; Hong YK
Cancer Lett; 2010 Feb; 288(2):251-60. PubMed ID: 19664879
[TBL] [Abstract][Full Text] [Related]
6. Combined cetuximab and celecoxib treatment exhibits a synergistic anticancer effect on human oral squamous cell carcinoma in vitro and in vivo.
Qian M; Qian D; Jing H; Li Y; Ma C; Zhou Y
Oncol Rep; 2014 Oct; 32(4):1681-8. PubMed ID: 25328959
[TBL] [Abstract][Full Text] [Related]
7. The effect of bevacizumab on human malignant melanoma cells with functional VEGF/VEGFR2 autocrine and intracrine signaling loops.
Adamcic U; Skowronski K; Peters C; Morrison J; Coomber BL
Neoplasia; 2012 Jul; 14(7):612-23. PubMed ID: 22904678
[TBL] [Abstract][Full Text] [Related]
8. [Arsenic trioxide restores ERα expression in ERα-negative human breast cancer cells and its treatment efficacy in combination with tamoxifen in xenografts in nude mice].
Zhang WJ; Xu DF; Fan QX; Wu XA; Wang F; Wang R; Wang LX
Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):645-51. PubMed ID: 23159075
[TBL] [Abstract][Full Text] [Related]
9. Celecoxib inhibits growth of human autosomal dominant polycystic kidney cyst-lining epithelial cells through the VEGF/Raf/MAPK/ERK signaling pathway.
Xu T; Wang NS; Fu LL; Ye CY; Yu SQ; Mei CL
Mol Biol Rep; 2012 Jul; 39(7):7743-53. PubMed ID: 22415852
[TBL] [Abstract][Full Text] [Related]
10. Autocrine VEGF signaling promotes cell proliferation through a PLC-dependent pathway and modulates Apatinib treatment efficacy in gastric cancer.
Lin Y; Zhai E; Liao B; Xu L; Zhang X; Peng S; He Y; Cai S; Zeng Z; Chen M
Oncotarget; 2017 Feb; 8(7):11990-12002. PubMed ID: 28061477
[TBL] [Abstract][Full Text] [Related]
11. BI2536--A PLK inhibitor augments paclitaxel efficacy in suppressing tamoxifen induced senescence and resistance in breast cancer cells.
Prashanth Kumar BN; Rajput S; Bharti R; Parida S; Mandal M
Biomed Pharmacother; 2015 Aug; 74():124-32. PubMed ID: 26349973
[TBL] [Abstract][Full Text] [Related]
12. KX-01, a novel Src kinase inhibitor directed toward the peptide substrate site, synergizes with tamoxifen in estrogen receptor α positive breast cancer.
Anbalagan M; Carrier L; Glodowski S; Hangauer D; Shan B; Rowan BG
Breast Cancer Res Treat; 2012 Apr; 132(2):391-409. PubMed ID: 21509526
[TBL] [Abstract][Full Text] [Related]
13. Crosstalk between VEGF and MTA1 signaling pathways contribute to aggressiveness of breast carcinoma.
Nagaraj SR; Shilpa P; Rachaiah K; Salimath BP
Mol Carcinog; 2015 May; 54(5):333-50. PubMed ID: 24265228
[TBL] [Abstract][Full Text] [Related]
14. Centchroman regulates breast cancer angiogenesis via inhibition of HIF-1α/VEGFR2 signalling axis.
Dewangan J; Kaushik S; Rath SK; Balapure AK
Life Sci; 2018 Jan; 193():9-19. PubMed ID: 29196053
[TBL] [Abstract][Full Text] [Related]
15. Specific blockade of VEGF and HER2 pathways results in greater growth inhibition of breast cancer xenografts that overexpress HER2.
Le XF; Mao W; Lu C; Thornton A; Heymach JV; Sood AK; Bast RC
Cell Cycle; 2008 Dec; 7(23):3747-58. PubMed ID: 19029832
[TBL] [Abstract][Full Text] [Related]
16. Piperine and Celecoxib synergistically inhibit colon cancer cell proliferation via modulating Wnt/β-catenin signaling pathway.
Srivastava S; Dewangan J; Mishra S; Divakar A; Chaturvedi S; Wahajuddin M; Kumar S; Rath SK
Phytomedicine; 2021 Apr; 84():153484. PubMed ID: 33667839
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells.
Basu GD; Pathangey LB; Tinder TL; Gendler SJ; Mukherjee P
Breast Cancer Res; 2005; 7(4):R422-35. PubMed ID: 15987447
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
Wang L; Chen W; Xie X; He Y; Bai X
Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
[TBL] [Abstract][Full Text] [Related]
19. Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients.
Mele T; Generali D; Fox S; Brizzi MP; Bersiga A; Milani M; Allevi G; Bonardi S; Aguggini S; Volante M; Dogliotti L; Bottini A; Harris A; Berruti A
Breast Cancer Res Treat; 2010 Oct; 123(3):795-804. PubMed ID: 20680681
[TBL] [Abstract][Full Text] [Related]
20. Tryptophan hydroxylase 1 and 5-HT
Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA
Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
